In-licensing of exclusive US commercialisation rights to Tadekinig alfa and preparations for a US marketing authorisation application
A specific drug in-licensing and development theme involving the in-licensing of exclusive US commercialisation rights to Tadekinig alfa from エービーツーバイオ社 and preparations for a US marketing authorisation application.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.